- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT00005384
Diet/Activity of Mexican American and Anglo Children
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
BACKGROUND:
It is well documented that the roots of cardiovascular diseases (CVD) are evident in childhood, and elevated levels of serum lipids, blood pressure and body fat are common in childhood. These risk factors are, in turn, related to childhood dietary and physical activity habits. To understand the early development of CVD, it is therefore important to study factors that influence diet and physical activity behaviors in children. Most studies concerned with the determinants of diet and physical activity in children are cross-sectional, limiting their utility for improving understanding of the development of these key health behaviors.
The study allowed prospective analyses of the behaviors over a significant portion of the prepubertal age range. Knowledge of the determinants, stability, and relationships of childhood dietary and physical activity behaviors to physiologic risk variables could be useful for setting priorities and designing public health interventions for the next generations of youth.
The major contribution of this San Diego SCAN study was in the longitudinal analysis of dietary and physical activity behaviors in children. The follow-up assessment of the 10-to 11-year-old cohort and their mothers produced data that substantially improved understanding of the determinants and tracking of children's dietary and physical activity behaviors, as well as their relations to CVD risk factors.
DESIGN NARRATIVE:
Selection of subjects studied was based on social learning/cognitive theory, which states that behaviors are a function of personal and environmental factors. The specific aims of the study were as follows: 1) To study the determinants of physical activity and dietary intake of fat, sodium, and calories, and changes in these behaviors in children from ages 4 to 10-11. 2) To determine the relationships between diet and physical activity practices and physiologic indicators of risk, such as blood pressure, adiposity, body mass, and serum lipoproteins at ages 4 to 10-11. 3) To describe the time trends and the degree of tracking of physical activity habits and nutritional intake of fat, sodium, and calories in children from ages 4 to 10-11. The study was renewed in 1999.
The study completion date listed in this record was obtained from the "End Date" entered in the Protocol Registration and Results System (PRS) record.
Studietype
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Studie plan
Hoe is de studie opgezet?
Medewerkers en onderzoekers
Onderzoekers
- Philip Nader, University of California, San Diego
Publicaties en nuttige links
Algemene publicaties
- Reaven P, Nader PR, Berry C, Hoy T. Cardiovascular disease insulin risk in Mexican-American and Anglo-American children and mothers. Pediatrics. 1998 Apr;101(4):E12. doi: 10.1542/peds.101.4.e12.
- Masu R, Sallis JF, Berry CC, Broyles SL, Elder JP, Nader PR. The relationship between health beliefs and behaviors and dietary intake in early adolescence. J Am Diet Assoc. 2002 Mar;102(3):421-4. doi: 10.1016/s0002-8223(02)90099-4. No abstract available.
- Sallis JF, Greenlee L, McKenzie TL, Broyles SL, Zive MM, Berry CC, Brennan J, Nader PR. Changes and tracking of physical activity across seven years in Mexican-American and European-American mothers. Women Health. 2001;34(4):1-14. doi: 10.1300/J013v34n04_01.
- Frank GC, Nader PR, Zive MM, Broyles SL, Brennan JJ. Retaining school children and families in community research: lessons from the Study of Children's Activity and Nutrition (SCAN). J Sch Health. 2003 Feb;73(2):51-7. doi: 10.1111/j.1746-1561.2003.tb03571.x.
Studie record data
Bestudeer belangrijke data
Studie start
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 4289
- R01HL052449 (Subsidie/contract van de Amerikaanse NIH)
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Hartziekten
-
University Hospital TuebingenVoltooidHeart Assist-apparaatDuitsland
-
Carmel Medical CenterOnbekendPneumoperitoneum | Heart Output StoornisIsraël
-
Region SkåneAanmelden op uitnodigingHartfalen New York Heart Association (NYHA) Klasse II | Hartfalen New York Heart Association (NYHA) Klasse IIIZweden
-
University of ChicagoVoltooidHartfalen | Heart Assist-apparaat | HyponatremischVerenigde Staten
-
Medical University of BialystokInstitute of Cardiology, Warsaw, Poland; Medical University of Lodz; Poznan University... en andere medewerkersNog niet aan het wervenHartfalen, systolisch | Hartfalen met verminderde ejectiefractie | Hartfalen New York Heart Association Klasse IV | Hartfalen New York Heart Association Klasse IIIPolen
-
Triple-Gene, LLCIntrexon Corporation; Precigen, IncVoltooidHart-en vaatziekten | Hartfalen | Heart-Assist-apparaatVerenigde Staten
-
University of WashingtonAmerican Heart AssociationVoltooidHartfalen, congestief | Mitochondriale verandering | Hartfalen New York Heart Association Klasse IVVerenigde Staten
-
Novartis PharmaceuticalsVoltooidPatiënten die de behandelingsperiode van 12 maanden van de kernstudie met succes hebben afgerond (de Novo Heart-ontvangers) die geïnteresseerd waren om behandeld te worden met EC-MPS
-
University of PennsylvaniaVoltooidPatiënten met primaire of secundaire diagnose Code of Intrntl Classification of Diseases, 9th Revision, (ICD-9-CM) 410 (Behalve wanneer het 5e cijfer 2 was)Verenigde Staten
-
SpringWorks Therapeutics, Inc.VerkrijgbaarNeurofibromatose Type 1-geassocieerde plexiforme neurofibromen | Histiocytisch neoplasma | Andere MAP-K Pathway Driven Diseases